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Proliferation of parathyroid cells negatively correlates with expression associated with humoral hypercalcemia [1, 2]. Three pep-
of parathyroid hormone-related protein in secondary parathyroid tides composed of 139, 141, and 173 amino acid residues
hyperplasia.
can be formed by alternate splicing of PTHrP messengerBackground. Parathyroid hormone–related protein (PTHrP) is now
suspected to act as an autocrine or paracrine regulator of cell growth or RNA (mRNA) [3]. The first 13 amino acid residues of
differentiation, although it was originally reported as a hypercalcemic the amino terminus show a high degree of homologysubstance in malignancies. This study was performed to assess the
with that of PTH, whereas amino acids 14 to 34 haverelationship between PTHrP expression and cell proliferation in human
parathyroid glands. important functions in binding to PTH receptors [4].
Methods. The localization of PTH and PTHrP was studied in 42 PTHrP reactions with PTH receptors in bone and kidneysamples of hyperplastic parathyroid from 14 long-term hemodialysis
are responsible for the hypercalcemia observed in malig-cases with immunohistochemistry and in situ hybridization. Results
were compared with proliferative activity (proliferating cell nuclear nant tumor cases with elevated serum PTHrP concentra-
antigen index: counts of proliferating cell nuclear antigen-positive cells/
tions [5]. Recently, PTHrP has been shown to be widely100 cells). The localization of the PTH/PTHrP receptor was also exam-
ined. Ten normal glands were studied as controls. distributed not only in neoplasms but also in normal
Results. In hyperplasia, cells positive for PTH, PTHrP, or both tissues [6]. Both PTHrP and common PTH/PTHrP re-
were observed immunohistochemically. The areas expressing PTHrP
ceptors are expressed in the same organs, such as bonemRNA completely coincided with those positive for PTHrP immuno-
histochemically. Oxyphilic or transitional oxyphilic cells were consis- [7], brain [8], the intestine [9], the endocrine pancreas
tently positive for PTHrP. PTH/PTHrP receptors were located in the [10], and the lung [11]. Inactivation of the PTHrP genecytoplasmic membrane in most parathyroid cells. Proliferating cell
results in an abnormal bone development [12]. Overex-nuclear antigen-positive cells were rare in normal glands with an index
of 0.22 6 0.09 (mean 6 sem). They were significantly increased in pression causes hyperplasia of pancreatic islets in trans-
hyperplastic cases but less for PTHrP-positive than for -negative cells genic mice [13]. Therefore, PTHrP is suspected to act as(1.25 6 0.16 as compared with 7.80 6 0.52; P , 0.0001).
an autocrine or a paracrine regulator of cell growth orConclusion. The observed low level of proliferation of PTHrP-posi-
tive cells suggests a functional role for PTHrP as a possible growth differentiation [6, 14]. Both PTH and PTHrP are ex-
suppressor in the human parathyroid.
pressed in the normal parathyroid gland in parathyroid
hyperplasia and in parathyroid adenomas [15–19]. PTH
and PTHrP have been colocalized in the same adenoma
The parathyroid hormone–related protein (PTHrP) cells and are secreted through the same constitutive path-
was originally isolated from human malignant tumors
way [20]. However, knowledge of the functional role of
PTHrP in this site is limited. We therefore designed this
study to cast light on the relationship between PTHrPKey words: parathyroid gland, hemodialysis, hyperplasia, PTHrP,
PTH, proliferation. production and cell proliferation in the human parathy-
roid gland. For this purpose, we first determined the
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erating cell nuclear antigen (PCNA), a cofactor of DNA and fluorescein (FITC)-conjugated rabbit antigoat immu-
noglobulins were used as second antibodies (DAKO,polymerase d [21], which has been established as a sensi-
tive marker of cell proliferation [22]. Triple immuno- Glostrup, Denmark). The quantitative analysis of PTHrP-
positive cells in the parathyroid glands was performedstaining for PTH/PTHrP and PCNA was performed on
the same histologic sections of parathyroid glands, allow- by the two independent reviewers using the following
grading criteria: 2 5 no positive cell; AF 5 a few positiveing direct comparisons to be made at the single cell level.
cells (below 5%); 1 5 5% to 30%; and 11 5 more
than 30%. After taking photomicrographs, the immuno-
METHODS
fluorescently stained parathyroid sections were treated
Parathyroid glands with 0.1 m glycine/HCl buffer to elute antibodies against
PTH or PTHrP and were then reacted with anti-PCNAForty-two samples of hyperplastic parathyroid glands
were obtained from 14 cases of secondary hyperparathy- antibody (DAKO; diluted at 1:100) for two hours at
room temperature (RT). After several washings in phos-roidism in chronic renal failure patients maintained on
long-term hemodialysis (Table 1). The study group con- phate-buffered saline solution (PBS) with 0.05% Tween
20 (PBS-T), the sections were reacted with goat anti-sisted of five males and nine females. The mean age at
parathyroidectomy was 50.0 6 3.0 (mean 6 sem) years. mouse IgG (H 1 L) antibody conjugated with 1 nm
colloidal gold particles (British BioCell International,The mean duration of hemodialysis was 14.4 6 1.2
(mean 6 sem) years before the operation. The cause of Cardiff, UK), diluted at 1:100, for 30 minutes at RT.
After several washings in distilled water, binding sitesrenal failure was chronic glomerulonephritis in all cases.
The concentrations of serum intact PTH were elevated were visualized using a silver enhancing kit (British Bio-
Cell International), and the sections were counterstainedin all cases before parathyroidectomy (mean 6 sem,
1484.0 6 265.0 pg/ml; normal range, 20.0 to 53.0 pg/ with methyl green. Additional sections were immuno-
stained routinely with avidin-biotin complex methodml) performed in these cases because of severe renal
osteodystrophy. Four parathyroid glands were resected after treatment with the anti-hPTHrP antibody. Immu-
nostaining for PTH/PTHrP common receptors was alsoin every case, and small fragments of parathyroid tissues
were autotransplanted. In all studied cases, the resected performed with the affinity purified polyclonal antibody
(Berkeley Antibody Company, Richmond, CA, USA).parathyroid glands were consistently enlarged. Histolog-
ically, there were no surrounding rim-like structures, but After reacting with primary antibody (diluted at 1:50)
and biotinylated second antibody (MaxITags; Shandon-interspersed fat tissue was evident with mild to moderate
enlargement. On the basis of the histologic appearance, Lipshaw, Pittsburgh, PA, USA), immunoreacted prod-
ucts in the parathyroid tissues were amplified by theparathyroid hyperplasias were divided into two subtypes:
diffuse (13 glands) and nodular (29 glands) [23], with tyramide signal amplification, known as catalyzed re-
porter deposition (NEL Life Science Products, Boston,mean weights and a sem of 1.26 6 0.34 g and 1.53 6 0.61
g, respectively. The difference between these two values MA, USA).
was not significant (Student’s t-test). As a control for
In situ hybridizationcell proliferation, 10 normal parathyroid glands were
obtained from two cases with benign thyroid tumors Expression of PTHrP mRNA was studied in 10 hyper-
plastic glands by in situ hybridization. The 33-mer oligo-and eight cases of esophageal carcinomas. These normal
parathyroid glands were attached to the resected thyroid nucleotide probe for human PTHrP, synthesized and
39 end-labeled with digoxigenin according the report oftissues or were contained in the dissected cervical lymph
nodes. Serum calcium levels were in the normal range Danks et al [24], was as follows: AAA TCG GAC GGG
GTG GTT CTT TGT GTT GGG AGA (JD2). Thein all cases. The glands comprised both parenchymal
cells and interstitial fat cells, and neither hyperplasia nor sense probe was used as a negative control. Formalin-
fixed and paraffin-embedded parathyroid tissues weremicroadenomas were histologically evident. The mean
age of this group was 49.7 6 5.8 (sem) years. examined. All solutions used for processing of thin sec-
tions, for the preparation of probes, for washing tissues,
Immunohistochemistry and for prehybridization and hybridization were pre-
pared with double-distilled water treated with 0.02%Double immunofluorescent staining for PTH and
PTHrP was performed as detailed in our earlier report diethylpyrocarbonate (Sigma, St. Louis, MO, USA).
Thin sections mounted on glass slides covered with tissue[20]. The monoclonal antibody against human (h) PTHrP
(1–34) was established in our laboratory, and goat anti- adhesive (3-aminopropyltriethoxysilane; Sigma) were
deparaffinized and treated with 0.3% Triton X-100 inhPTH antibodies were obtained from the Nichols In-
stitute (San Juan Capistrano, CA, USA) and Nihon PBS for 15 minutes at RT. After several washes in PBS,
they were postfixed with 4% paraformaldehyde in PBSMediphysics Co. Ltd. (Nishinomiya, Japan). Rhodamin
(TRITC)-conjugated rabbit antimouse immunoglobulins for five minutes and were further washed and then im-
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Table 1. Clinicopathological data for the studied cases
Duration of
PTHrPAge hemodialysis
PTHa Weight Histological PTHrP in situ
Case years pg/ml Locationb g typingc immunostainingd hybridizationd
1 52 10.0 1100 RU 1.16 NH 2 AF
RL 0.71 NH 2 ND
LU 0.25 NH 1 1
LL 0.44 NH 1 ND
2 58 5.0 2899 LL 0.07 NH 11 11
LU 3.07 DH 2 2
RU ND DH 2 AF
RL ND DH 1 ND
3 45 14.0 LU 1.30 DH 1 ND
LL 0.47 DH 1 ND
RL 0.23 NH AF AF
RU 0.28 NH 2 ND
4 60 14.0 605 RU 0.34 NH 1 ND
RL 0.13 NH 1 ND
LU 0.73 NH 1 ND
LL 0.49 DH 2 ND
5 21 11.0 720 RU 1.64 DH AF AF
LL 2.09 DH 2 ND
6 61 24.0 1054 LU 0.28 DH 11 1
RU 0.22 NH 1 ND
RL 3.24 DH 2 ND
7 49 19.0 2029 LL ND NH 2 ND
8 46 15.0 1307 LU ND NH 2 ND
LL ND NH 1 ND
RU ND DH AF ND
9 51 19.0 1056 LU 2.20 NH 1 1
LL 0.60 NH 2 ND
RU 0.22 DH 11 ND
RL 0.70 NH 1 ND
10 45 16.0 1888 RU ND NH 1 ND
RL 0.50 NH 2 ND
11 61 14.0 ND RU 2.07 NH 2 ND
12 48 13.0 1271 LU 12.50 NH AF ND
RU 1.76 NH 11 11
LL 0.32 DH 2 ND
13 63 13.0 456 LU ND NH 11 ND
LL ND NH 1 ND
RU ND NH 11 ND
RL ND NH 11 ND
14 42 14.0 3426 RL 2.88 NH 2 ND
RU 0.58 NH AF ND
RL 2.88 NH AF ND
ND is not determined.
a Normal range of serum intact PTH, 20.0–53.0 pg/ml
b Abbreviations are: LU, left upper; LL, left lower; RU, right upper; RL, right lower
c Abbreviations are: DH, diffuse hyperplasia; NH, nodular hyperplasia
d Quantitative estimation of PTHrP positive cells: (2) no positive cells; (AF) a few positive cells (below 5%); (1) 5–30%; (11) more than 30%
mersed in 3% hydrogenperoxide in methanol for 10 min- hybridization solution were applied to each tissue section
under glass coverslips, and incubation was in the 25%utes at RT to block intrinsic peroxidase activity. After
ethanol dehydration, sections were placed in a 25% for- formamide humid chamber for 12 to 18 hours at RT.
Coverslips were removed in 4 3 SSC, and the sectionsmamide humid chamber and reacted with prehybridiza-
tion buffer containing 25% deionized formamide in 2 3 were washed with three changes of 3 3 SSC, two changes
of 0.2 3 SSC (prewarmed at 378C), and finally, threesaline-sodium citrate (SSC) buffer for one hour at RT.
The hybridization buffer consisted of 2 3 SSC, 25% changes of 2 3 SSC for five minutes each. Hybridization
signals were amplified and detected with the followingdeionized formamide, 0.1% polyvinylpyrolidone (Sigma),
0.1% Ficoll (Sigma), 1% bovine serum albumin (fraction immunohistochemical steps. After washing in PBS-T, the
tissue sections were reacted with sheep antidigoxigeninV; Boehringer Mannheim, Mannheim, Germany), 250
mg/ml salmon sperm DNA (type Iis; Sigma), and 250 antibody (Boehringer Mannheim) diluted at 1:250 with
PBS containing 1% bovine serum albumin (PBS-B) formg/ml yeast tRNA (Boehringer Mannheim). The probe
concentration was 2.0 ng/ml. Twenty to 30 microliters of one hour at RT. After washing in PBS-T, the sections
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Table 2. Quantitative estimation of PTHrP positive cells (immunohistochemistry)
Quantity of PTHrP positive cells %
PTHrP positive glands
Histological typing Total glands % 2 AF 1 11
Diffuse hyperplasia 13 7 (54) 6 (47) 2 (15) 3 (23) 2 (15)
Nodular hyperplasia 29 20 (69) 9 (31) 4 (14) 11 (38) 5 (17)
Total 42 27 (64) 15 (36) 6 (14) 14 (33) 7 (17)
Definitions are: 2, no positive cell; AF, a few positive cells (below 5%); 1, 5 to 30%; 11, more than 30%.
were then reacted with biotinylated rabbit antisheep IgG as PTHrP (Fig. 1). Cells with the same immunoreactivity
also showed a tendency to group together in diffuse(H 1 L) antibody (Vector Laboratories, Burlingame,
hyperplasia samples. PTH was distributed along the cyto-CA, USA) diluted at 1:200 in PBS-B for 30 minutes at
plasmic membranes linearly or fine granularly, whereasRT. After three washes with PBS-T, the signals were
PTHrP showed a tendency to be distributed diffusely oramplified by the tyramide signal amplification [25]. The
coarse granularly in the cytoplasm. Histologic examina-sections were incubated with horseradish peroxidase
tion of restained hyperplasia tissues after immunohisto-conjugated streptoavidin in the biotinyl tyramide ampli-
chemical examination revealed a tendency for PTHrP-fication kit for 30 minutes at RT, were washed thoroughly
positive nodules to consist of oxyphilic cells and for PTH-with five changes of PBS-T for five minutes each, and
positive nodules to consist of chief cells. The nodules
were incubated with biotinyl tyramide for exactly 10 positive for both PTH and PTHrP usually consisted of
minutes at RT. The sections were then washed with chief cells or transitional oxyphilic cells. The dominant
four changes of PBS-T and reacted with horse radish type of parenchymal cells was that of entirely PTH posi-
peroxidase-labeled streptoavidin-biotin complex (Strept tive in all hyperplastic parathyroid glands. The quantita-
ABC complex/HRP; DAKO) for 30 minutes at RT and tive estimation of PTHrP-positive cells, entirely PTHrP
finally with 2% diaminobenzidine for five minutes. positive, and positive for both PTH and PTHrP revealed
that half of hyperplastic parathyroid glands consisted of
Statistical analysis considerable amounts of PTHrP-positive cells, 5% to
30% in one third and more than 30% in 17% of parathy-The numbers of PCNA-positive cells were counted
roid hyperplasia (Table 2).per 100 parathyroid cells to provide a PCNA index, esti-
mated for PTHrP-positive and PTHrP-negative areas Distribution of PTHrP mRNA
separately. For this purpose, counts were made in at least
Hybridized signals were detected in only the speci-four different areas in each parathyroid gland. PCNA
mens reacted with the antisense probe for PTHrP
indices were statistically analyzed by two-way ANOVA
mRNA and were negative with the sense probe. The
using the generalized linear model procedure with SAS/ areas expressing PTHrP mRNA in hyperplastic glands
STAT software (SAS Institute Inc., Cary, NC, USA), well coincided with those positive for PTHrP immuno-
because of the imbalance in sample numbers among the histochemically (Fig. 2). In the PTHrP-positive areas in
study groups [26]. Significance was concluded with a P secondary hyperplasia cases, the intensity of detected
value of ,0.05. signals for PTHrP mRNA in the cytoplasm was uneven,
being strong in some cells and weak in others. Most
hybridized signals were detected in the cytoplasm, mainly
RESULTS near the basal lamina, but weak signals were detected
in nuclei as well. There was no apparent difference inDistribution of PTH and PTHrP
the intensities of detected signals between nodular andThe immunohistochemical results are summarized in
diffuse hyperplasia cases.Tables 1 and 2. All parathyroid glands immunohisto-
chemically examined were positive for PTH. Of the 42 Proliferative activity of parathyroid cells
samples of parathyroid hyperplasia secondary to chronic PCNA-positive cells were very rare in the normal
renal failure, 27 (64%) demonstrated PTHrP staining, parathyroid gland, and staining could only be found in
with no significant difference being observed between PTHrP-negative chief cells in four of the cases. The num-
the diffuse (9/13) and nodular (20/29) types. In nodular bers of PCNA-positive cells were markedly increased
parathyroid hyperplasia, each nodule was homogeneously in hyperplasia. Their densities differed from nodule to
comprised of one type of parathyroid cells, entirely PTH nodule in nodular hyperplasia, although they appeared
evenly distributed within individual nodules (Fig. 3a).positive or PTHrP positive or positive for PTH as well
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Fig. 1. Distribution of PTH and PTHrP in parathyroid hyperplasia secondary to chronic renal failure. Hyperplastic parathyroid tissues were
double immunostained for PTH (green fluorescence) and for PTHrP (red fluorescence). The distribution of PTH and PTHrP was heterogeneous
in nodular hyperplasia, although each nodule was homogeneously composed of one type of parathyroid cells, entirely PTH-positive cells (a,
asterisk), positive for both PTH and PTHrP (b), or positive only for PTHrP (c). Magnification a, 336; b and c, 372.
Fig. 2. In situ hybridization for PTHrP mRNA. Serial sections were used for histologic examination (a), immunohistochemistry for PTHrP (b),
and in situ hybridization for PTHrP mRNA (c). The oxyphil cell area (a, center-left) is responsible for PTHrP production at the level of protein
(b) or mRNA (c) (3125). (d) Higher magnification of in situ hybridization signals in a PTHrP-positive area. Most PTHrP mRNA appears distributed
in the cytoplasm, mainly in the basal portions of the cells (arrows). The density of the signals for PTHrP mRNA is uneven with considerable
heterogeneity between cells despite their homogeneous PTHrP immunostaining. Insert: Negative control with the sense probe (3220).
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Fig. 3. (left) Heterogeneity of cell proliferation in human parathyroid
glands. (a) Proliferating cell nuclear antigen (PCNA) immunoreactivity
in a case of nodular parathyroid hyperplasia. PCNA-positive nuclei are
stained black. The level of cell proliferation is heterogeneous, with the
density of PCNA positive cells in the nodule on the left (A) being
higher than in that on the right (B) or in the internodular area. Immuno-
staining with gold colloidal particle-conjugated secondary antibodies
and silver enhancement (3115). (b) Immunohistochemistry for PTH
and PTHrP. In the center of the figure, there is a small nodule consisting
of a uniform population of PTHrP-positive cells (encircled with arrows),
whereas the surrounding parathyroid tissue is comprised of PTH-posi-
tive cells. Double-immunofluorescence method (3230). (c) PCNA im-
munostaining of the same tissue section used for the immunohistochem-
istry for PTH/PTHrP in Figure 2b. The density of PCNA positive cells
in the small nodule with PTHrP positive cells in Figure 2b (encircled
with arrows) is extremely low comparing to the surrounding parathyroid
tissue that is positive for PTH. Immunostaining with gold colloidal
particle-conjugated secondary antibody and silver enhancement after
double immunofluorescent staining for PTH/PTHrP (3230).
Fig. 5. The localization of PTH/PTHrP receptors in parathyroid hyper-
plasia secondary to chronic renal failure. PTH/PTHrP receptors are
located along the cell membrane in most hyperplastic parathyroid cells.
Immunoreactive products are shown in a dark brown color (49,49-diami-
nobenzidine as a chromogen). Immunostaining enhanced by the tyra-
mide signal amplification method (3340).
tive) cells in normal parathyroid glands because the num-
ber of both PTHrP-positive and PCNA-positive cells was
too small to allow analysis. The relation of histologic
appearance and immunohistochemical findings for para-
thyroid cells to the PCNA index was statistically ana-
lyzed by two-way ANOVA using the generalized linear
model procedure. The mean and sem values for PCNA
indices were 0.22 6 0.09 (N 5 32) in the normal parathy-
roid gland and 5.32 6 0.46 (N 5 99) in hyperplasia cases.
The mean and sem for parathyroid cells positive onlyThe heterogeneity in cell proliferative activity exactly
coincided with the heterogeneity of the immunoreactiv- for PTH with negative immunoreactivity for PTHrP were
4.99 6 0.46 (N 5 95; normal and hyperplasia cases),ity of the parathyroid cells for PTH or PTHrP (Fig. 3 b,
c). Therefore, separate PCNA indices (counts of PCNA- whereas the respective values for PTHrP-positive cells
were 1.48 6 0.15 (N 5 36, hyperplasia cases). In parathy-positive cells/100 cells) for PTHrP-positive and -negative
cell areas were generated for hyperplasia. We could only roid hyperplasia cases, the mean and sem values for
PTHrP-negative cells were 7.80 6 0.52 (N 5 63), andestimate a PCNA index for PTHrP-negative (PTH-posi-
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show a nodular appearance [27], some nodules consisting
of chief cells and others of oxyphilic or transitional oxy-
philic cells. It has been suggested that the functional
levels of the parathyroid cells also differ from nodule to
nodule. Fukuda et al have reported that vitamin D–
receptor expression is suppressed in nodular parathyroid
hyperplasia secondary to chronic renal failure with long-
term hemodialysis [23]. They showed the receptor den-
sity to be heterogeneous but uniform within individual
nodules. Because the physiological role of vitamin D is to
suppress cell growth or PTH secretion in the parathyroid
glands, receptor depletion may result in accelerated cell
growth or vitamin D–resistant hypersecretion of PTH
[28]. This study of the distribution of PTH and PTHrP
revealed another distinct heterogeneity in secondary
parathyroid nodular hyperplasia; that is, each nodule was
homogeneously comprised of one type of parathyroid
cells, exclusively PTH positive, PTHrP positive, or posi-
tive for PTH as well as PTHrP. Cells with the same
immunoreactivity also showed a tendency to group to-
gether in diffuse hyperplasia cases. In addition, our sensi-
tive in situ hybridization technique clearly demonstrat-
ed the distribution of the parathyroid cells expressing
PTHrP mRNA to coincide well with that of the cells
immunohistochemically positive for PTHrP. Therefore,
it is evident that the cells in hyperplastic parathyroid
glands positive for PTHrP are actively producing PTHrP.
In our earlier report, we demonstrated that hyperplastic
Fig. 4. Proliferation activity of the parathyroid cells. PCNA indices parathyroid cells from patients with chronic renal failure
were measured for cells positive only for PTH (PTHrP negative cells) are able to secrete PTHrP depending on the extracellularand for those positive for PTHrP or both PTHrP and PTH (PTHrP
calcium levels [19]. There are two different types of PTHpositive cells). The values for the PTHrP negative cells were significantly
higher than those for PTHrP positive cells (*P , 0.0001) in hyperplasia receptors: one is common for PTH and PTHrP [8] and
cases. As compared with normal glands, the cases of hyperplasia demon- the other is specific for PTH [29]. PTH/PTHrP commonstrated significant increase (**P , 0.0001). The error bars indicate sem
receptors are known to be widely distributed in manyvalues.
organs and are postulated to function as paracrine or
autocrine receptors [14]. In this study, we showed that
most hyperplastic parathyroid cells expressed PTH/
for PTHrP-positive cells, the mean and sem were 1.25 6 PTHrP receptors along cell membranes. Considerable
0.16 (N 5 36). PCNA indices for hyperplasia cases were amounts of parathyroid cells expressed PTHrP in hyper-
significantly higher than the value for normal parathy- plastic glands. Therefore, PTHrP can act as a possible
roid glands (P , 0.0001), and the PTHrP-negative cells paracrine or autocrine substance in parathyroid hyper-
(cells positive only for PTH) consistently demonstrated plasia secondary to chronic renal failure. The prolifera-
significantly higher indices than PTHrP-positive cells (P , tive activity of the parathyroid cells evaluated with
0.0001) (Fig. 4). PCNA immunolabeling was significantly increased in
secondary parathyroid hyperplasia in this study with con-
Distribution of PTH/PTHrP receptor siderable internodule variation. The heterogeneity in the
PCNA labeling of parathyroid cells coincided exactlyMost parathyroid cells were immunohistochemically
with the heterogeneity in their hormone production, withpositive for the PTH/PTHrP receptor. The receptors
proliferation correlating in a negative fashion withwere distributed along the cytoplasmic membrane of the
PTHrP expression. Recently, evidence has accumulatedparathyroid cells (Fig. 5).
that PTHrP acts as a paracrine or an autocrine regulator
that can control cell proliferation as well as differentia-
DISCUSSION tion [12, 14, 30]. Several reports have appeared of inhibi-
It is well known that hyperplastic parathyroid glands in tory effects of PTHrP on cell proliferation in osteoblastic
cells [31, 32], lymphocytes [33], keratinocytes [34–36],renal-failure patients with long-term hemodialysis often
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vascular smooth muscle cells [37], hepatoma cells [38], APPENDIX
and alveolar pneumocytes [39]. On the other hand, a Abbreviations used in this article are: h, human; mRNA, messenger
RNA; PBS, phosphate-buffered saline solution; PBS-B, phosphate-stimulatory influence of PTHrP was noted for a rat carci-
buffered saline solution with bovine serum albumin; PBS-T, phosphate-noma cell line [40], renal tubular cells [41], and a chon-
buffered saline solution with Tween; PCNA, proliferating cell nuclear
drocytic cell line [42]. However, there has been no report antigen; PTHrP, parathyroid hormone–related protein; RT, room tem-
perature; SSC, saline-sodium citrate.about the function of PTHrP in this regard in human
parathyroid glands. From our results, it is tempting to
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